ReviewReviews in endocrine & metabolic disorders2022
Pasireotide-a novel somatostatin receptor ligand after 20 years of use.
Marek Bolanowski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it